Matthieu Montes

Matthieu Montes has a diverse work experience in the fields of academia and pharmaceuticals. Matthieu is currently a Senior Member at Institut universitaire de France (IUF) since 2023. Matthieu previously worked as a Professor at Cnam (Conservatoire national des arts et métiers) from September 2016. Prior to that, they held the position of Assistant Professor, Tenured at the same organization from September 2009 to September 2016.

Matthieu Montes also has experience in the pharmaceutical industry. Matthieu is the Founder of Qubit Pharmaceuticals since May 2020. Matthieu has served as a Bioinformatics drug discovery advisor at Peptinov SAS from February 2010 to 2014, and at Vaxconsulting from April 2010 to December 2013.

Additionally, Matthieu Montes has an academic background. Matthieu worked as a Teaching and Research Assistant at CNAM from September 2007 to August 2009. Matthieu started their career as a PhD Student at Université Paris Descartes in 2004, where they remained until 2007. Overall, Matthieu Montes has gained valuable experience in academia, drug discovery, and pharmaceutical consulting throughout their career.

Matthieu Montes has a comprehensive educational background in the field of biochemistry and pharmaceutical sciences. Matthieu started their educational journey in 1999 at ESTBA, earning a BTS degree in Biochemistry in 2001.

Matthieu then pursued further studies at Université Paris Cité, where they obtained a DEA/MSc degree in Bioinformatics in 2004. Matthieu continued their education at the same institution, completing their PhD in Pharmaceutical sciences in 2007.

Following their PhD, Matthieu Montes focused on molecular and structural biochemistry, enrolling at Paris-Sud University (Paris XI) in 2014. Matthieu is currently pursuing a Habilitation à Diriger des Recherches degree in this field.

Based on the provided information, Matthieu Montes has continuously developed their expertise in the biochemistry and pharmaceutical sciences fields, emphasizing molecular and structural biochemistry in their recent studies.